Sarcoma, Synovial - 20 Studies Found
Completed |
: Everolimus in Combination With Imatinib Mesylate in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Soft Tissue Sarcoma :
: 2011-01-21 : |
Recruiting |
: Recombinant Interferon Gamma in Treating Patients With Soft Tissue Sarcoma :
|
Active, not recruiting |
: Lorvotuzumab Mertansine in Treating Younger Patients With Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma :
|
Recruiting |
: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma :
|
Recruiting |
: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer :
|
Recruiting |
: Detection of Circulating Tumor Cells in Patients With Sarcomas :
|
Completed |
: Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive Chemotherapy :
|
Completed |
: Sorafenib and Dacarbazine in Soft Tissue Sarcoma :
|